HEALTH ADVANCE INC - HADV STOCK NEWS

Health Advance, Inc. (OTC PINK:HADV) announces the second printing of Dr. Alvin Pettle's book, My Prescription for Life, reflecting high reader satisfaction. This collaboration focuses on launching immune-boosting nutraceuticals and health solutions derived from Dr. Pettle's clinical experience. The first product range targets immune support, with plans for additional offerings in reproductive health. The company aims to enhance personal wellness and has garnered positive feedback from patients. The release is part of Health Advance's broader initiative to develop proprietary health products.

Health Advance, Inc (HADV) announced significant progress in addressing lingering health issues post-COVID. The company has selected a contract manufacturer for its proprietary supplement aimed at improving well-being among these patients. Two phases of the product launch include initial trial manufacturing and subsequent larger-scale production. Dr. Alvin Pettle leads the science team, focusing on creating user-friendly supplement kits. With rising demand for such products, Health Advance positions itself to capitalize on this growing market.

Health Advance, Inc. (OTC PINK:HADV) has commenced distribution of its innovative CBD infused de-alcoholized wine under its 66° Beverage Company brand. This product is the first of its kind licensed in New York, featuring a unique formulation available in Rosé, White, and Red Wine variants, each containing 25mg of CBD.

Targeting health-conscious consumers, the wines are made from non-GMO California grapes and contain lower calories and sugar. The initial product allocation is aimed at qualified retailers and marketing organizations to boost brand outreach.

Health Advance, Inc. (OTC PINK:HADV) has initiated production of its innovative CBD infused de-alcoholized wine, branding it under the new 66° Beverage Company. The first manufacturing run allocates 19,400 units for early customers, launching in August. The company has partnered with Publicity For Good to enhance its market presence and communicate effectively with industry stakeholders. Health Advance aims to position this unique beverage as a significant player in the expanding adult lifestyle market, reflecting a commitment to innovation and consumer engagement.

Health Advance, Inc. (OTC PINK:HADV) announced the upcoming launch of its CBD infused de-alcoholized wine under the brand 66° Beverage Company, with the first batch expected for distribution by the end of July 2022. The company recently secured a production license from New York State, enabling it to proceed with its innovative beverage offerings. Industry trends indicate a growing interest in non-alcoholic beverages, with the global market nearing $1 trillion. The president emphasized the quality of retailer interest and indicated that cash flow from sales will be reflected in Q3 2022 filings.

Health Advance, Inc. (OTC PINK:HADV) has appointed David Katz, MBA, as President and Co-Founder of its new CBD infused wine beverage brand, 66° Beverage Company. The brand's launch will occur through the joint venture with Courtship Wines, which recently received a license from New York State's Cannabinoid Hemp Program. An initial production run of 60,000 bottles in three varietals is underway. Katz brings significant experience from the food and beverage sectors, aiming to position the brand as an innovator in the adult lifestyle beverage market.

Health Advance, Inc. (OTC PINK:HADV) has received licensing approval from New York State for its CBD infused beverages through its joint venture, Courtship Wines. This marks a significant milestone in the company's strategic development since 2021, enabling them to launch their CBD product line. The management indicates that adequate funding is secured, and initial orders are already in place. Upcoming announcements will detail product offerings, including flavor and packaging, as the company activates its manufacturing processes.

Health Advance Inc (OTC PINK:HADV) announced a joint venture named Health Advance CV to provide treatment options for individuals suffering from lingering effects post-COVID. The venture will offer curated nutraceutical pouches utilizing proprietary infusion techniques for improved efficacy. Led by Dr. Alvin Pettle, the initiative aims to simplify supplement combinations for better compliance. Health Advance CV will collaborate with leading contract manufacturers to produce quality health products, targeting the growing global demand. More updates will follow as the venture progresses.

Health Advance, Inc. (OTC PINK:HADV) has been awarded shared distributorship of the Rapid Response™ COVID-19 Antigen Rapid Test Device by BTNX, Inc. This development enables Health Advance to start sales of the approved COVID-19 testing device, which is critical for addressing the persistent effects of 'Long COVID.' The company, which has a solid track record in sales and training, is set to operate its distribution through a joint venture that will be detailed later. Moreover, the company plans to launch CBD infused beverages through a new subsidiary by Q4 2021.